Pulmonary toxicity of ABVD chemotherapy and G-CSF in Hodgkin's disease: possible synergy
- 1 October 1993
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 342 (8877) , 988
- https://doi.org/10.1016/0140-6736(93)92033-p
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF — clinical attentionAnnals of Hematology, 1993
- Neutrophil priming by granulocyte colony stimulating factor and its modulation by protein kinase inhibitorsBiochemical Pharmacology, 1992
- Possible Mechanisms of Bleomycin-Induced FibrosisClinics in Chest Medicine, 1990
- Bleomycin-Induced Pulmonary ToxicityClinics in Chest Medicine, 1990
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975